Minimize workflows and maximize productivity in a HIPAA + 21 CFR Part 11 compliant data capture platform

 

in partnership with

 
 

Up to 50% of a trial budget is dedicated to labor.

One study coordinator can spend over 180 hours on a single study, often on redundant tasks that are necessary to the trial’s success but time consuming to complete manually.


That’s why we built Avi™, the biomedical research industry’s first automation platform to automatically handle protocol-specified data collection and safety monitoring.

We save critical resources for Sponsors and CROs by making data management processes more efficient, allowing you to distribute study staff in a way that maximizes outcomes.

Our Mission


Compliance

Ensure GCP and ICH guidelines are being met at all times in a trial.

Personalization

Decrease dropout rates by enhancing the patient user experience and decreasing staff burden.

Monitoring

Better critical safety data and real-time collection of important outcome variables.

Worry less, achieve more.


We automate your compliance and streamline data collection through naturalistic, quantitative, and objective electronic collection methods in a secure and robust platform.

Continuous real world data

Capture mobile patient questionnaires and critical biomarkers securely and accurately. Revolutionize your trials’ safety monitoring with data streams from wearable sensors like heartrate monitors, glucometers, rescue inhalers, and more – inside and outside the clinic.

Placeholder
Placeholder

Automatic EHR monitoring

Avi™ automatically scans subject records from over 5500 medical systems for unscheduled patient medications, visits, and hospitalizations that could negatively affect study outcomes.

Better communication

We built our platform to answer common subject questions without CRA intervention, meaning more accurate, faster HIPAA-compliant communications between study staff and patients.

Placeholder
Placeholder

Powerful analytics

Intuitive risk analysis of adverse events and biomarkers to visualize emerging dangerous trends in source data.


Why Avi?

Our flagship product’s namesake is Avicenna, an Persian philosopher and writer of the first treatise on early clinical trials. Avicenna was a thought pioneer in many aspects of clinical trials we take for granted today, like the invention of the placebo, control groups, and applying the scientific method to drug research.